|
|
|
Volumn 291, Issue 5501, 2001, Pages 25-26
|
|
Preventing hair loss from chemotherapy
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLIN DEPENDENT KINASE 2 INHIBITOR;
CYCLIN DEPENDENT KINASE INHIBITOR;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
ETOPOSIDE;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC AGENT;
CDK2 PROTEIN, HUMAN;
CDK2 PROTEIN, MOUSE;
CDK2 PROTEIN, RAT;
CYCLIN DEPENDENT KINASE;
CYCLIN DEPENDENT KINASE 2;
ENZYME INHIBITOR;
PROTEIN SERINE THREONINE KINASE;
ALOPECIA;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
CANCER CHEMOTHERAPY;
CONTROLLED STUDY;
DRUG DESIGN;
ENZYME INHIBITION;
HAIR FOLLICLE;
MOUSE;
NEWBORN;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
ANIMAL;
CHEMICALLY INDUCED DISORDER;
DRUG ANTAGONISM;
HUMAN;
METABOLISM;
RAT;
ALOPECIA;
ANIMALS;
ANIMALS, NEWBORN;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CDC2-CDC28 KINASES;
CYCLIN-DEPENDENT KINASE 2;
CYCLIN-DEPENDENT KINASES;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
ENZYME INHIBITORS;
ETOPOSIDE;
HUMANS;
MICE;
PROTEIN-SERINE-THREONINE KINASES;
RATS;
|
|
EID: 0035808581
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (5)
|
|
References (0)
|